Jefferies analyst Brian Tanquilut reiterated a Buy rating and $125.00 price target on Tenet Healthcare (NYSE: THC) after the company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE